Company Profile

Glyciome LLC
Profile last edited on: 12/26/2022      CAGE: 8E7D8      UEI: HANMJ8Z3YRV3

Business Identifier: Sustainable - non irritant causing products - for total body hygiene
Year Founded
2019
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

University of Idaho Research Park Suite 219 | 958 Lochsa Street
Post Falls, ID 83854
   (509) 448-4223
   info@glyciome.com
   www.glyciome.com
Location: Single
Congr. District: 01
County: Spokane

Public Profile

Glyciome LLC is structured around development of urogenital and personal care products designed to counter everyday issues, including the high levels of allergies and irritation resulting from existing products. Originally based in Valleyford WA, the firm now operates in University of Idaho Research Park facilities in Post Falls, Idaho. The firm's founder invented Pre-Seed® Fertility-Friendly personal lubricant decades as the first safe personal lubricant for trying-to-conceive (TTC) couples when trying to become pregnant. Anchored in addressing her own fertility issues and her work with infertility patients, Pre-Seed was the first-ever lubricant reviewed by the FDA as safe for use by TTC couples. Glyciome is developing urogenital and personal care products in answer to everyday issues, including the high levels of allergies and irritation resulting from existing products. The firm's novel product platform cleanses and freshens with no sting, no itch, no irritation across body surfaces to work with the healthy human microbiome and protective barriers. The firm is also bringing accessible, sustainable products for total body hygiene to users across age-groups, including diaper care and toilet hygiene aimed to reduce wet wipe and toilet paper waste, and the chronic irritation these products can cause.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $454,968
Project Title: Cervical Cancer Prevention Prebiotic Device

Key People / Management

  Joanna Elizabeth Ellington -- Founder, CEO and President

Company News

There are no news available.